Crowe Third-Party Risk Management Services for Life Sciences

Life sciences organizations rely increasingly on outside service providers, focusing in-house resources on research and development of the next blockbuster innovation. Contracting out processes can provide cost and quality advantages, but only if relationships are monitored. Leaders of pharmaceutical, biotechnology, and medical device companies need to assess the quality and security of vendors, outsourcers, product resellers, servicers, and others.